Pharma News FDA approves epcoritamab for the treatment of R/R diffuse large B-cell lymphoma Read more
Pharma News Vyxeos liposomal now reimbursed in Belgium for patients with untreated high-risk AML Read more
Pharma News Pirtobrutinib gets FDA approval for relapsed or refractory mantle cell lymphoma Read more
Pharma News FDA approves pirtobrutinib for the treatment of advanced relapsed/refractory mantle cell lymph... Read more
Pharma News FDA accepts license application of reformulated denileukin diftitox for patients with CTCL Read more
Pharma News FDA approval for brentuximab vedotin for children with high-risk Hodgkin lymphoma Read more
